Coronavirus Latest News
UK approves second Covid vaccine targeting Omicron variant
Pfizer/BioNTech ‘bivalent’ booster, targeting original and Omicron variants, approved along with Moderna jab
A second “bivalent” coronavirus vaccine has been approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for individuals aged 12 and over.
The regulator confirmed on Saturday that Pfizer/BioNTech’s vaccine had met its standards of safety, quality and effectiveness and had been approved for the UK autumn booster programme.
Read the original article at The Guardian